\
&
Contact us
\
&
Contact us
Published on | 2 weeks ago
Programmes Climate, Energy, Mobility EITWhat is it about ?
The European institute of innovation and technology (EIT) has nine independant subdivisions called knowledge and innovation communites (KIC). They are a group made up of partners from business, academia and research (innovation) and are funded by the European Union. They regularly launch calls to stimulate new businesses and develop talented people.
The InnoNext Call by EIT Climate-KIC aims to achieve those goals by supporting start-ups and talented EIT graduates that can deliver innovative solutions for pressing climate issues. It is an initiative in collaboration with the European Innovation Council.
It opens fresh opportunities for EIT Community members to participate in fully funded Innovation Internships across Europe. Through this platform, graduates from EIT Label programmes and EIT-supported startups can access tailored placements that connect academic talent with business needs.
Who can take part ?
a) talents
b) startups and SMEs
You can apply for this programme at the bottom of this website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
